Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Adel
Adel Aali, Irvine, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100004611 | Wound Shield With Enclosed Vacuum Space - A wound shield including a conformable frame to circumscribe a wound and warm water circulating system to maintain a warm environment. Any suitable dressing may be secured over the conformable frame providing separation between the wound and the dressing. The wound frame may provide pressure relief around a wound or pressure sore to permit healing. A conformable frame may be composed of one or more layers of any suitable material and may include adhesive on one or more surfaces to secure the frame to the wound site and or to secure the dressing to the conformable frame. | 01-07-2010 |
| 20100234818 | Dressing Substrate - A wound shield to manage repetitive access stress may include a conformable substrate to circumscribe a wound. Any suitable dressing may be secured to the conformable substrate providing separation between the wound and the dressing. The wound substrate may provide a site for attachment of adhesive dressings to shield the patient's skin from the pain of repetitive access and or removal of the dressings. A conformable substrate may be composed of one or more layers of any suitable material and may include adhesive on one or more surfaces to secure the substrate to the wound site and or to secure the dressing to the conformable substrate. A wound substrate may include strong adhesive to secure the substrate to the patients skin. The conformable wound substrate will be formed of any suitable non-absorbent material to permit long term application adjacent a wound. Thus many dressings may be applied and removed from a single wound substrate shielding the patient's skin from repetitive insult. A wound substrate according to the present disclosure may also be combined with a conformable frame to provide exudate management and or pressure distribution around a wound. | 09-16-2010 |
| 20100312159 | Secondary Wound Dressings for Securing Primary Dressings and Managing Fluid from Wounds, and Methods of Using Same - Under one aspect, an apparatus includes a primary dressing configured for application over a region of compromised skin and including fluid-absorbing material; and a secondary dressing configured for application over the primary dressing. The secondary dressing applies pressure to the primary dressing so as to maintain the primary dressing in place over the region of compromised skin and promote the flow of fluid from the region of compromised skin into the fluid-absorbing material, and allows moisture in the fluid to evaporate from the fluid-absorbing material. Under another aspect, a dressing includes a fabric layer sized to cover a region of compromised skin; a foam layer secured to the fabric layer and having an aperture defined therein sized to cover the region of compromised skin; and a biocompatible adhesive layer disposed on the foam layer. Methods of applying the dressing also are provided. | 12-09-2010 |
| 20110015557 | Systems And Methods For Protecting Incisions - The present invention provides systems and methods for protecting wounds, such as surgical incisions. In one embodiment, a dressing for protecting a wound includes: a support cushion configured to surround the wound, the support cushion having sidewalls defining a major axis and a minor axis, the support cushion including at least two perforations that traverse the sidewalls at offset locations; a reservoir configured to be suspended over and in engagement with the support cushion; and a cover configured to be positioned over the reservoir. The at least two perforations may define first and second interlocking J-shaped portions. The support cushion may include a wicking portion configured to surround the wound and a hydrophobic portion configured to surround the hydrophobic portion. The wicking portion may be configured to transfer fluid from the wound to the reservoir. Methods of applying the dressing, and kits including the dressing, also are provided. | 01-20-2011 |
| 20110034888 | WOUND SHIELD - A preformed wound shield includes a frame formed of one or more layers of suitable material and any suitable covering. Exudate absorbing or transporting material may also be one of two or more layers of material forming the frame. | 02-10-2011 |
Adel Afridi, Danvers, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120010468 | SYSTEM OF DISPOSABLE CONTOURED SLEEVES FOR FLEXIBLE ENDOSCOPES - A system of for labeling and organizing de-contaminated and cleaned flexible endoscopes with coded one-use disposable sheaths. The sheaths are specifically contoured and coded for specific types of endoscopes. The endoscopes can only be removed from sheaths by tearing, slicing, cutting or otherwise breaking the sheaths open. This product system reduces the risk of patient to patient cross-contamination by labeling cleaned endoscopes for easy identification by medical care professionals. | 01-12-2012 |
Adel Bakhtiarova, Woodside, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120122212 | TGF-BETA PATHWAY INHIBITORS FOR ENHANCEMENT OF CELLULAR REPROGRAMMING OF HUMAN CELLS - The present disclosure provides methods and compositions to enhance reprogramming in human cells. In some cases, the method includes contacting human cells with an inhibitor of the TGFβ pathway, for example a TGFβ receptor (TGFβR) inhibitor in combination with one or more induction factors. | 05-17-2012 |
Adel Bazerghi, Oakville CA
| Patent application number | Description | Published |
|---|---|---|
| 20110029438 | SYSTEM AND METHOD FOR DELIVERY OF RETAIL-CHANNEL-SPECIFIC CONTENT TO A MEDIA DEVICE - A system comprising: a memory; at least one network entity operatively coupled to the memory and configured for: receiving an identifier of a media device; receiving an identity of a retail channel used to acquire the media device; storing in the memory an association between the identity of the retail channel and the identifier of the media device; and causing content specific to the retail channel to be transmitted to the media device over a communications network in response to determining a presence of the media device on the communications network. Also, a media device, comprising: a network interface; a user interface; and a processing entity. The processing entity is configured for: identifying the media device to an external entity via the network interface; receiving retail-channel-specific content over the network interface; and conveying the retail-channel-specific content via the user interface through a retail-channel-specific application installed on the media device. | 02-03-2011 |
Adel Elseri, Edmonton CA
| Patent application number | Description | Published |
|---|---|---|
| 20120073066 | TONGUE-MOUNTED CLEANING ARTICLE - The invention is directed to a tongue-mounted cleaning article for caring for the teeth and gums having an elongated body defining an inner cavity having a contour of the tongue and optionally, apertures therethrough; an open end having an annular elastic member for removably attaching the article to the tongue; and a closed end having pyramidal protuberances disposed over a portion or the entirety of its surface to project outwardly for cleaning the teeth and gums. | 03-29-2012 |
Adel Garas, Wollongong AU
| Patent application number | Description | Published |
|---|---|---|
| 20100167995 | PEPTOID COMPOUNDS - The invention relates to new peptoid compounds of formula (I), as well as their use in the treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms, and to compositions thereof. | 07-01-2010 |
| 20120108499 | PEPTOID COMPOUNDS - The invention relates to new peptoid compounds of formula (I), as well as their use in the treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms, and to compositions thereof. | 05-03-2012 |
Adel Halaka, Holmdel, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100095695 | Temperature controlled compressor for electrical energy savings in enclosed room cooling - An electrical energy use saving system for the sales of purchasable amounts of beer, soda, bottled water, meat, vegetables, fruit, dairy, eggs or seafood products kept in a walk-in cooler, reach-in cooler or display case whose temperature is to be maintained includes a compressor, a thermostat, a suction fan and a thermometer in a network by which the cooler or case is cooled by outdoors ambient air when outside temperatures are cold and where the cooler or case is cooled by the compressor when outside temperatures are warm. | 04-22-2010 |
Adel Homsy, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20090235954 | Method and a washing system for washing turbines - A method for cleaning turbines on-line comprises extracting water from air directly at a turbine site having a turbine and treating the air and the extracted water to obtain extremely clean water having a conductivity of less than 3. This extremely clean water is then fed to the turbine to clean the turbine blades while the turbine is on-line. Preferably the extremely clean water is fed through a deionizer before being fed to the turbine. | 09-24-2009 |
Adel Joobeur, Milford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090091734 | Illumination System - A coherence remover is provided. In an embodiment the coherence remover includes a first mirror and a second mirror coupled to the first mirror. The coherence remover is configured to receive an input beam. Each of the first and second mirrors is configured to reflect a respective portion of the input beam to produce respective one or more intermediate beams. The intermediate beams collectively form an output beam that has a reduced coherence compared to the input beam. | 04-09-2009 |
| 20090168072 | Illumination System - A coherence remover includes a first partially reflective surface and a second partially reflective surface. The coherence remover is configured to receive an input beam. Each of the first and second reflective surfaces is configured to reflect a respective portion of the input beam to produce respective one or more intermediate beams. The intermediate beams collectively form an output beam that has a reduced coherence compared to the input beam. | 07-02-2009 |
| 20090257053 | High Numerical Aperture Catadioptric Objectives Without Obscuration and Applications Thereof - Disclosed are high numerical (NA) catadioptric objectives without a central obscuration, and applications thereof. Such objectives can operate through a wide spectral bandwidth of radiation, including deep ultraviolet (DUV) radiation. Importantly, refractive elements in the catadioptric objectives can be manufactured from a single type of material (such as, for example, CaF | 10-15-2009 |
| 20100149505 | EUV Mask Inspection System - Disclosed are apparatuses, methods, and lithographic systems for EUV mask inspection. An EUV mask inspection system can include an EUV illumination source, an optical system, and an image sensor. The EUV illumination source can be a standalone illumination system or integrated into the lithographic system, where the EUV illumination source can be configured to illuminate an EUV radiation beam onto a target portion of a mask. The optical system can be configured to receive at least a portion of a reflected EUV radiation beam from the target portion of the mask. Further, the image sensor can be configured to detect an aerial image corresponding to the portion of the reflected EUV radiation beam. The EUV mask inspection system can also include a data analysis device configured to analyze the aerial image for mask defects. | 06-17-2010 |
| 20100163757 | Pulse Modifier with Adjustable Etendue - A beam modifying unit increases both temporal pulse length and Etendue of an illumination beam. The pulse modifying unit receives an input pulse of radiation and emits one or more corresponding output pulses of radiation. A beam splitter divides the incoming pulse into a first and a second pulse portion, and directs the first pulse portion along a second optical path and the second portion along a first optical path as a portion of an output beam. The second optical path includes a divergence optical element. A first and a second mirror, each with a radius of curvature, are disposed facing each other with a predetermined separation, and receive the second pulse portion to redirect the second portion, such that the optical path of the second portion through the pulse modifier is longer than that of the first portion, and the separation is less than radius of curvature. | 07-01-2010 |
| 20110255173 | Pulse Modifier with Adjustable Etendue - A beam modifying unit increases both temporal pulse length and Etendue of an illumination beam. The pulse modifying unit receives an input pulse of radiation and emits one or more corresponding output pulses of radiation. A beam splitter divides the incoming pulse into a first and a second pulse portion, and directs the first pulse portion along a second optical path and the second portion along a first optical path as a portion of an output beam. The second optical path includes a divergence optical element. A first and a second mirror, each with a radius of curvature, are disposed facing each other with a predetermined separation, and receive the second pulse portion to redirect the second portion, such that the optical path of the second portion through the pulse modifier is longer than that of the first portion, and the separation is less than radius of curvature. | 10-20-2011 |
| 20120026607 | High Numerical Aperture Catadioptric Objectives without Obscuration and Applications Thereof - Disclosed are high numerical (NA) catadioptric objectives without a central obscuration, and applications thereof. Such objectives can operate through a wide spectral bandwidth of radiation, including deep ultraviolet (DUV) radiation. Importantly, refractive elements in the catadioptric objectives can be manufactured from a single type of material (such as, for example, CaF | 02-02-2012 |
Adel Kebsi, Thiais FR
| Patent application number | Description | Published |
|---|---|---|
| 20100137355 | NITROGENOUS HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND USE THEREOF AS ANTIBACTERIAL MEDICAMENTS - The invention concerns nitrogenated heterocyclic compounds, their preparation and use as antibacterial drugs, compounds of general formula (I) | 06-03-2010 |
Adel Kebsi, Romainville FR
| Patent application number | Description | Published |
|---|---|---|
| 20100087648 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL DRUGS - The invention relates to nitrogen-containing heterocyclic compounds of general formula (I) | 04-08-2010 |
| 20100093784 | NOVEL HETEROCYCLIC NITROGENOUS COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL MEDICAMENTS - The invention relates to nitrogenous heterocyclic compounds of formula | 04-15-2010 |
Adel Nefzi, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080255218 | Melanin-Concentrating Hormone Receptor Antagonists and Methods of Use - This invention relates generally to N-benzylamino cyclic thioureas, pharmaceutical compositions containing them, and their use as antagonists of melanin-concentrating hormone receptor (MCH receptor). | 10-16-2008 |
| 20090043099 | Methods and compositions for derepression of IAP-inhibited caspase - The invention provides isolated agents having novel chemical structures and possessing superior activity as derepressors of IAP inhibited caspase. The invention further provides a method of derepressing an IAP-inhibited caspase. The invention further provides assay methods employing labeled compounds of the invention, especially fluorescent labeled compounds. | 02-12-2009 |
| 20110183358 | METHODS AND COMPOSITIONS FOR DEREPRESSION OF IAP-INHIBITED CASPASE - The invention provides isolated agents having novel chemical structures and possessing superior activity as derepressors of IAP inhibited caspase. The invention further provides a method of derepressing an IAP-inhibited caspase. The invention further provides assay methods employing labeled compounds of the invention, especially fluorescent labeled compounds. | 07-28-2011 |
Adel Nibu, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20100101581 | HOLLOW STRUCTURE AND METHOD/TOOL FOR MANUFACTURING SAME - A method for producing a filled hollow structure includes producing an open hollow structure of a first material, positioning the open hollow structure on a tool adapted to hold the open hollow structure, filling the open hollow structure with a filler medium, and closing the filled open hollow structure with a second material. A hollow structure may be produced by such method, and a tool may be structured to perform such method. | 04-29-2010 |
Adel Nibu, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110023882 | Surface structure on patient interface - The present invention relates to the surface structure of a plastic material and particularly of silicone surfaces. More particularly, the present invention relates to the surface structure of the surfaces of a breathing mask assembly or a patient interface to be used for supplying breathing gas to a patient. Such patient interface for providing respiratory gas to a patient comprises a contact surface for contacting a patient's skin, wherein at least a part of said contact surface is a structured surface. | 02-03-2011 |
Adel Penhasi, Nolon IL
| Patent application number | Description | Published |
|---|---|---|
| 20110052648 | ORAL MODIFIED-RELEASE FORMULATIONS CONTAINING THIAZEPINES - An oral modified-release formulation using Quetiapine or pharmaceutically acceptable salts thereof as an active ingredient, while avoiding the use of a gelling material. As used herein, the term “modified release” includes but is not limited to one or more of controlled release, sustained release, prolonged release and extended release. | 03-03-2011 |
Adel Rafai Far, Mount-Royal CA
| Patent application number | Description | Published |
|---|---|---|
| 20110046041 | METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS - The present invention is directed to methods of inhibition, delay of formation, treatment, prophylaxis and/or prevention of infections caused by bacteria that exhibit tolerance to antimicrobial agents, including slow growing, stationary-phase and biofilm forming bacteria, through the use of glycopeptide antibiotics, such as oritavancin. | 02-24-2011 |
Adel Rafai Far, St. Laurent CA
| Patent application number | Description | Published |
|---|---|---|
| 20110178001 | PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS - The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis. | 07-21-2011 |
Adel Rafai Far, Ville Mont-Royal CA
| Patent application number | Description | Published |
|---|---|---|
| 20080287396 | Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections - The present invention relates to phosphonated fluoroquinolones, antibacterial analogs thereof, and methods of using such compounds. These compounds are useful as antibiotics for prevention and/or the treatment of bone and joint infections, especially for the prevention and/or treatment of osteomyelitis. | 11-20-2008 |
| 20100113333 | PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS - The present invention is directed to antimicrobial compounds which have an affinity for binding bones. More particularly, the invention is directed to phosphonated derivatives of glycopeptide or lipoglycopeptide antibiotics. These compounds are useful as antibiotics for the prevention or treatment of bone and joint infections, especially for the prevention and treatment of osteomyelitis. | 05-06-2010 |
| 20110263534 | PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS - The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis. | 10-27-2011 |
Adel Shalata, Sakhnin IL
| Patent application number | Description | Published |
|---|---|---|
| 20100077496 | MO-1, A Gene Associated With Morbid Obesity - MO-1 is a newly identified gene and gene product associated with morbid obesity. Isolated MO-1 nucleic acids, MO-1 polypeptides, oligonucleotides that hybridize to MO-1 nucleic adds, and vectors, including expression vectors, comprising MO-1 nucleic acids are disclosed, as are isolated host cells, antibodies, transgenic non-human animals, compositions, and kits relating to MO-1. Methods of detecting the presence of MO-1 nucleic acid, screening for agents which affect MO-1 activity, and screening for MO-1 variants are also disclosed. | 03-25-2010 |
Adel Shrufi, Bellevue, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20100223559 | TECHNIQUES FOR INTEGRATING STRUCTURED ACCOUNTING DATA WITH UNSTRUCTURED DATA - Various technologies and techniques are disclosed for integrating structured accounting data with unstructured data. From an application that manages structured accounting data related to an entity, a user selection is received to create a document container for a collaboration tool. The document container is used for storing unstructured data related to the entity. In response to the selection of the create option, a site creation service is launched for automatically creating the document container using settings previously specified by an administrator on a configuration screen of the application. Once the document container is created, unstructured data related to the entity is stored in the document container. The user can view and navigate between the structured accounting data and unstructured data without having to leave the application. Unstructured data is automatically published to the document container for the entity as users interact with the application. | 09-02-2010 |
Adel Shrufi, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20120041991 | SCALABLE AND EXTENSIBLE FRAMEWORK FOR DATA-DRIVEN WEB SERVICES - A layered architecture for a web service is provided with a data tier, object representation, data transformation, and a service tier. Scalability is achieved by relying on relatively high degree of decoupling, lightweight data interaction, and reducing overhead of transaction demands. Custom web services can be built on top and leverage the capabilities of the flexible framework including lightweight transaction support, event-based business logic extensibility, and efficient data contract binding. | 02-16-2012 |
Adel Vilallobos, Mission Hills, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100055178 | ENTERIC-COATED CREATINE COMPOSITIONS AND METHODS OF USE THEREOF - Compositions and methods are provided for supplementing dietary creatine and facilitating absorption of creatine, comprising an enteric-coated creatine pharmaceutical formulation that may be provided as a tablet, capsules, pellet, and microbead in the form of creatine monohydrate, creatine phosphate, creatine cytrate, creatine pyruvate, or creatine ethyl ester. | 03-04-2010 |
Adel Youakim, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080254506 | Claudin polypeptides - This invention relates to new members of the human Claudin polypeptide family, to methods of making such polypeptides, and to methods of using them to treat Claudin-associated conditions and to identify compounds that alter Claudin polypeptide activities. | 10-16-2008 |